Vol 17, No 4 (2024)
Review paper
Published online: 2024-12-19
The role of viruses in the pathogenesis of skin cancer in patients with chronic kidney disease and kidney transplant recipients
1
, 1
, 1
DOI: 10.5603/rdatf.104115
Renal Disease and Transplantation Forum 2024;17(4):142-147.
Abstract
In patients with chronic kidney disease and after
kidney transplantation, the risk of cancer increases
significantly due to the impaired function of the
immune system. It is caused by the presence of
uremic toxins or the use of immunosuppressive
drugs and recurrent infections. It was found that in
both groups of patients the most common type of
cancer are non-melanoma skin cancers and among
them squamous cell carcinoma (sSCC). Viruses remain
the key carcinogens in both sSCC and other
primary skin cancers.
Keywords: CKDcancerKTxskin cancers
References
- Shirazian S, Starakiewicz P, Latcha S. Cancer Screening in End-Stage Kidney Disease. Adv Chronic Kidney Dis. 2021; 28(5): 502–508.e1.
- Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol. 2010; 23: 253–262.
- Chinnadurai R, Flanagan E, Jayson GC, et al. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study. BMC Nephrol. 2019; 20(1): 380.
- Granata S, Tessari G, Stallone G, et al. Skin cancer in solid organ transplant recipients: still an open problem. Front Med (Lausanne). 2023; 10: 1189680.
- Martin-Gorgojo A, Gilaberte Y, Nagore E. Vitamin D and Skin Cancer: An Epidemiological, Patient-Centered Update and Review. Nutrients. 2021; 13(12).
- Cheung CY, Tang SC. An update on cancer after kidney transplantation. Nephrol Dial Transplant. 2019; 34(6): 914–920.
- Massicotte-Azarniouch D, Detwiler RK, Hu Y, et al. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis. Nephrol Dial Transplant. 2023; 38(9): 2009–2018.
- Massicotte-Azarniouch D, Noel JA, Knoll GA. Epidemiology of Cancer in Kidney Transplant Recipients. Semin Nephrol. 2024; 44(1): 151494.
- Hortlund M, Arroyo Mühr LS, Storm H, et al. Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer. 2017; 140(5): 1091–1101.
- Imko-Walczuk B, Ankudowicz A, Jaśkiewicz J, et al. Skin cancer in organ transplant recipients. Dermatology Review/Przegląd Dermatologiczny. 2011; 98: 91–103.
- Nabi Z, Zahid T, Nabi R. Post Renal Transplant Malignancies; A Basic Concept. J Ayub Med Coll Abbottabad. 2023; 35(4): 664–668.
- Euvrard S, Kanitakis J, Claudy A. Neoplastic Skin Diseases in Organ Transplant Recipients. American Journal of Cancer. 2002; 1(2): 109–120.
- Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers. 2007; 23(4): 247–259.
- Que SK, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018; 78(2): 237–247.
- Becerril S, Corchado-Cobos R, García-Sancha N, et al. Viruses and Skin Cancer. Int J Mol Sci. 2021; 22(10).
- Nunes E, Talpe-Nunes V, Sichero L. Epidemiology and biology of cutaneous human papillomavirus. Clinics. 2018; 73.
- Ponticelli C, Cucchiari D, Bencini P. Skin cancer in kidney transplant recipients. J Nephrol. 2014; 27(4): 385–394.
- Köhler A, Forschner T, Meyer T, et al. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol. 2007; 156(5): 1078–1080.
- Doorbar J. The papillomavirus life cycle. Journal of Clinical Virology. 2005; 32: 7–15.
- Cheng S, Schmidt-Grimminger DC, Murant T, et al. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 1995; 9(19): 2335–2349.
- DiMaio D, Petti L. The E5 proteins. Virology. 2013; 445(1-2): 99–114.
- Bedell MA, Hudson JB, Golub TR, et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol. 1991; 65(5): 2254–2260.
- Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003; 49(5): 832–841.
- Llombart B, Requena C, Cruz J. Update on Merkel Cell Carcinoma: Epidemiology, Etiopathogenesis, Clinical Features, Diagnosis, and Staging. Actas Dermosifiliogr. 2017; 108(2): 108–119.
- Arron ST, Canavan T, Yu SS. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation. J Am Acad Dermatol. 2014; 71(4): 684–690.
- Garrett GL, Zargham H, Schulman JM, et al. Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature. JAAD Case Rep. 2015; 1(6): S29–S32.
- Muirhead R, Ritchie DM. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol (R Coll Radiol). 2007; 19(1): 96.
- Friedlaender MM, Rubinger D, Rosenbaum E, et al. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation. 2002; 73(11): 1849–1850.
- Wu H, Pye I, Chinnadurai R. Merkel Cell Carcinoma in Kidney Transplant Recipients. Dermato. 2023; 3(1): 25–50.
- Rohner E, Wyss N, Trelle S, et al. HHV-8 seroprevalence: a global view. Syst Rev. 2014; 3: 11.
- Bais C, Van Geelen A, Eroles P, et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell. 2003; 3(2): 131–143.
- Campistol JM, Schena FP. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors. Nephrol Dial Transplant. 2007; 22 Suppl 1: i17–i22.
